APO Research
Talk to an analyst

APO RESEARCH · REPORT

Breast Cancer Screening

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

Selected research

Industry Growth & Trends

Global Breast Cancer Screening Industry Growth and Trends Forecast to 2032

26 December 202597 pages

Choose your research edition.

Industry ResearchBreast Cancer Screening Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Breast Cancer Screening Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Breast Cancer Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Breast Cancer Screening Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Breast Cancer Screening Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.

Read the full market overview

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.

Report Scope

This report provides a structured, data-driven view of the global Breast Cancer Screening market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Breast Cancer Screening market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Breast Cancer Screening market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Breast Cancer Screening.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Breast Cancer Screening market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Breast Cancer Screening Market by Company

Hologic

GE Healthcare

Siemen Healthineers

Philips Healthcare

Canon Medical

Fujifilm

Metaltronica

Sino Medical-Device

IMS Srl

Breast Cancer Screening Segment by Type

Mammography Screening

Breast Magnetic Resonance Imaging (MRI) Screening

Breast Ultrasound Screening

Breast Cancer Screening Segment by Application

Hospital

Clinic

Breast Cancer Screening Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast Cancer Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Breast Cancer Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast Cancer Screening.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Mammography Screening Table 2. Major Company of Breast Magnetic Resonance Imaging (MRI) Screening Table 3. Major Company of Breast Ultrasound Screening Table 4. Global Breast Cancer Screening Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Breast Cancer Screening Sales by Type (2021-2026) & (Units) Table 6. Global Breast Cancer Screening Sales Market Share in Volume by Type (2021-2026) Table 7. Global Breast Cancer Screening Sales by Type (2021-2026) & (US$ Million) Table 8. Global Breast Cancer Screening Sales Market Share in Value by Type (2021-2026) Table 9. Global Breast Cancer Screening Price by Type (2021-2026) & (K USD/Unit) Table 10. Global Breast Cancer Screening Sales by Type (2027-2032) & (Units) Table 11. Global Breast Cancer Screening Sales Market Share in Volume by Type (2027-2032) Table 12. Global Breast Cancer Screening Sales by Type (2027-2032) & (US$ Million) Table 13. Global Breast Cancer Screening Sales Market Share in Value by Type (2027-2032) Table 14. Global Breast Cancer Screening Price by Type (2027-2032) & (K USD/Unit) Table 15. North America Breast Cancer Screening Sales by Type (2021-2026) & (Units) Table 16. North America Breast Cancer Screening Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Breast Cancer Screening Sales by Type (2021-2026) & (Units) Table 18. Europe Breast Cancer Screening Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Breast Cancer Screening Sales by Type (2021-2026) & (Units) Table 20. Asia-Pacific Breast Cancer Screening Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Breast Cancer Screening Sales by Type (2021-2026) & (Units) Table 22. Latin America Breast Cancer Screening Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Breast Cancer Screening Sales by Type (2021-2026) & (Units) Table 24. Middle East and Africa Breast Cancer Screening Sales by Type (2021-2026) & (US$ Million) Table 25. Breast Cancer Screening Industry Trends Table 26. Breast Cancer Screening Industry Drivers Table 27. Breast Cancer Screening Industry Opportunities and Challenges Table 28. Breast Cancer Screening Industry Restraints Table 29. Global Breast Cancer Screening Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Breast Cancer Screening Revenue Market Share by Company (2021-2026) Table 31. Global Breast Cancer Screening Sales by Company (2021-2026) & (Units) Table 32. Global Breast Cancer Screening Sales Share by Company (2021-2026) Table 33. Global Breast Cancer Screening Market Price by Company (2021-2026) & (K USD/Unit) Table 34. Global Breast Cancer Screening Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Breast Cancer Screening Major Company Production Sites and Headquarters Table 36. Global Breast Cancer Screening Company, Product Type & Application Table 37. Global Breast Cancer Screening Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Breast Cancer Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Breast Cancer Screening Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Breast Cancer Screening Sales by Region (2021-2026) & (Units) Table 42. Global Breast Cancer Screening Sales Market Share in Volume by Region (2021-2026) Table 43. Global Breast Cancer Screening Sales by Region (2021-2026) & (US$ Million) Table 44. Global Breast Cancer Screening Sales Market Share in Value by Region (2021-2026) Table 45. Global Breast Cancer Screening Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 46. Global Breast Cancer Screening Sales by Region (2027-2032) & (Units) Table 47. Global Breast Cancer Screening Sales Market Share in Volume by Region (2027-2032) Table 48. Global Breast Cancer Screening Sales by Region (2027-2032) & (US$ Million) Table 49. Global Breast Cancer Screening Sales Market Share in Value by Region (2027-2032) Table 50. Global Breast Cancer Screening Sales (Units), Value (US$ Million), Price (K USD/Unit) and Gross Margin (2027-2032) Table 51. Global Breast Cancer Screening Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Breast Cancer Screening Sales by Application (2021-2026) & (Units) Table 53. Global Breast Cancer Screening Sales Market Share in Volume by Application (2021-2026) Table 54. Global Breast Cancer Screening Sales by Application (2021-2026) & (US$ Million) Table 55. Global Breast Cancer Screening Sales Market Share in Value by Application (2021-2026) Table 56. Global Breast Cancer Screening Price by Application (2021-2026) & (K USD/Unit) Table 57. Global Breast Cancer Screening Sales by Application (2027-2032) & (Units) Table 58. Global Breast Cancer Screening Sales Market Share in Volume by Application (2027-2032) Table 59. Global Breast Cancer Screening Sales by Application (2027-2032) & (US$ Million) Table 60. Global Breast Cancer Screening Sales Market Share in Value by Application (2027-2032) Table 61. Global Breast Cancer Screening Price by Application (2027-2032) & (K USD/Unit) Table 62. North America Breast Cancer Screening Sales by Application (2021-2026) & (Units) Table 63. North America Breast Cancer Screening Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Breast Cancer Screening Sales by Application (2021-2026) & (Units) Table 65. Europe Breast Cancer Screening Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Breast Cancer Screening Sales by Application (2021-2026) & (Units) Table 67. Asia-Pacific Breast Cancer Screening Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Breast Cancer Screening Sales by Application (2021-2026) & (Units) Table 69. Latin America Breast Cancer Screening Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Breast Cancer Screening Sales by Application (2021-2026) & (Units) Table 71. Middle East and Africa Breast Cancer Screening Sales by Application (2021-2026) & (US$ Million) Table 72. Hologic Company Information Table 73. Hologic Business Overview Table 74. Hologic Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 75. Hologic Breast Cancer Screening Product Portfolio Table 76. Hologic Recent Development Table 77. GE Healthcare Company Information Table 78. GE Healthcare Business Overview Table 79. GE Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 80. GE Healthcare Breast Cancer Screening Product Portfolio Table 81. GE Healthcare Recent Development Table 82. Siemen Healthineers Company Information Table 83. Siemen Healthineers Business Overview Table 84. Siemen Healthineers Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 85. Siemen Healthineers Breast Cancer Screening Product Portfolio Table 86. Siemen Healthineers Recent Development Table 87. Philips Healthcare Company Information Table 88. Philips Healthcare Business Overview Table 89. Philips Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 90. Philips Healthcare Breast Cancer Screening Product Portfolio Table 91. Philips Healthcare Recent Development Table 92. Canon Medical Company Information Table 93. Canon Medical Business Overview Table 94. Canon Medical Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 95. Canon Medical Breast Cancer Screening Product Portfolio Table 96. Canon Medical Recent Development Table 97. Fujifilm Company Information Table 98. Fujifilm Business Overview Table 99. Fujifilm Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 100. Fujifilm Breast Cancer Screening Product Portfolio Table 101. Fujifilm Recent Development Table 102. Metaltronica Company Information Table 103. Metaltronica Business Overview Table 104. Metaltronica Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 105. Metaltronica Breast Cancer Screening Product Portfolio Table 106. Metaltronica Recent Development Table 107. Sino Medical-Device Company Information Table 108. Sino Medical-Device Business Overview Table 109. Sino Medical-Device Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 110. Sino Medical-Device Breast Cancer Screening Product Portfolio Table 111. Sino Medical-Device Recent Development Table 112. IMS Srl Company Information Table 113. IMS Srl Business Overview Table 114. IMS Srl Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 115. IMS Srl Breast Cancer Screening Product Portfolio Table 116. IMS Srl Recent Development Table 117. North America Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 118. North America Breast Cancer Screening Sales by Country (2021-2026) & (Units) Table 119. North America Breast Cancer Screening Sales Market Share by Country (2021-2026) Table 120. North America Breast Cancer Screening Sales Forecast by Country (2027-2032) & (Units) Table 121. North America Breast Cancer Screening Sales Market Share Forecast by Country (2027-2032) Table 122. North America Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Breast Cancer Screening Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Breast Cancer Screening Market Share by Country (2021-2026) Table 125. North America Breast Cancer Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Breast Cancer Screening Market Share Forecast by Country (2027-2032) Table 127. Europe Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 128. Europe Breast Cancer Screening Sales by Country (2021-2026) & (Units) Table 129. Europe Breast Cancer Screening Sales Market Share by Country (2021-2026) Table 130. Europe Breast Cancer Screening Sales Forecast by Country (2027-2032) & (Units) Table 131. Europe Breast Cancer Screening Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Breast Cancer Screening Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Breast Cancer Screening Market Share by Country (2021-2026) Table 135. Europe Breast Cancer Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Breast Cancer Screening Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Breast Cancer Screening Sales by Country (2021-2026) & (Units) Table 139. Asia-Pacific Breast Cancer Screening Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Breast Cancer Screening Sales Forecast by Country (2027-2032) & (Units) Table 141. Asia-Pacific Breast Cancer Screening Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Breast Cancer Screening Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Breast Cancer Screening Market Share by Country (2021-2026) Table 145. Asia-Pacific Breast Cancer Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Breast Cancer Screening Market Share Forecast by Country (2027-2032) Table 147. Latin America Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 148. Latin America Breast Cancer Screening Sales by Country (2021-2026) & (Units) Table 149. Latin America Breast Cancer Screening Sales Market Share by Country (2021-2026) Table 150. Latin America Breast Cancer Screening Sales Forecast by Country (2027-2032) & (Units) Table 151. Latin America Breast Cancer Screening Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Breast Cancer Screening Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Breast Cancer Screening Market Share by Country (2021-2026) Table 155. Latin America Breast Cancer Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Breast Cancer Screening Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Breast Cancer Screening Sales by Country (2021-2026) & (Units) Table 159. Middle East and Africa Breast Cancer Screening Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Breast Cancer Screening Sales Forecast by Country (2027-2032) & (Units) Table 161. Middle East and Africa Breast Cancer Screening Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Breast Cancer Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Breast Cancer Screening Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Breast Cancer Screening Market Share by Country (2021-2026) Table 165. Middle East and Africa Breast Cancer Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Breast Cancer Screening Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Breast Cancer Screening Distributors List Table 170. Breast Cancer Screening Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Breast Cancer Screening Image Figure 2. Global Breast Cancer Screening Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Breast Cancer Screening Market Size (2021-2032) & (US$ Million) Figure 4. Global Breast Cancer Screening Sales (2021-2032) & (Units) Figure 5. Mammography Screening Image Figure 6. Global Mammography Screening Sales YoY Growth (2021-2032) & (Units) Figure 7. Breast Magnetic Resonance Imaging (MRI) Screening Image Figure 8. Global Breast Magnetic Resonance Imaging (MRI) Screening Sales YoY Growth (2021-2032) & (Units) Figure 9. Breast Ultrasound Screening Image Figure 10. Global Breast Ultrasound Screening Sales YoY Growth (2021-2032) & (Units) Figure 11. Global Breast Cancer Screening Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Breast Cancer Screening Market Share by Type 2025 VS 2032 Figure 13. North America Breast Cancer Screening Sales Market Share in Volume by Type in 2025 Figure 14. North America Breast Cancer Screening Sales Market Share in Value by Type in 2025 Figure 15. Europe Breast Cancer Screening Sales Market Share in Volume by Type in 2025 Figure 16. Europe Breast Cancer Screening Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Breast Cancer Screening Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Breast Cancer Screening Sales Market Share in Value by Type in 2025 Figure 19. Latin America Breast Cancer Screening Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Breast Cancer Screening Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Breast Cancer Screening Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Breast Cancer Screening Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Breast Cancer Screening Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Breast Cancer Screening Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Breast Cancer Screening Market Share by Application 2025 VS 2032 Figure 31. North America Breast Cancer Screening Sales Market Share in Volume by Application in 2025 Figure 32. North America Breast Cancer Screening Sales Market Share in Value by Application in 2025 Figure 33. Europe Breast Cancer Screening Sales Market Share in Volume by Application in 2025 Figure 34. Europe Breast Cancer Screening Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Breast Cancer Screening Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Breast Cancer Screening Sales Market Share in Value by Application in 2025 Figure 37. Latin America Breast Cancer Screening Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Breast Cancer Screening Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Breast Cancer Screening Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Breast Cancer Screening Sales Market Share in Value by Application in 2025 Figure 41. North America Breast Cancer Screening Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Breast Cancer Screening Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Breast Cancer Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Breast Cancer Screening Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Breast Cancer Screening Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Breast Cancer Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Breast Cancer Screening Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Breast Cancer Screening Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Breast Cancer Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Breast Cancer Screening Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Breast Cancer Screening Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Breast Cancer Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Breast Cancer Screening Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Breast Cancer Screening Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Breast Cancer Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Breast Cancer Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Breast Cancer Screening Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Breast Cancer Screening Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Mammography Screening
  • Breast Magnetic Resonance Imaging (MRI) Screening
  • Breast Ultrasound Screening
Applications
  • Hospital
  • Clinic
Companies covered
  • Hologic
  • GE Healthcare
  • Siemen Healthineers
  • Philips Healthcare
  • Canon Medical
  • Fujifilm
  • Metaltronica
  • Sino Medical-Device
  • IMS Srl

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Breast Cancer Screening Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Breast Cancer Screening Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Breast Cancer Screening Market by Type
  6. 1.3.1 Mammography Screening
  7. 1.3.2 Breast Magnetic Resonance Imaging (MRI) Screening
  8. 1.3.3 Breast Ultrasound Screening
  9. 1.4 Global Breast Cancer Screening Market Size by Type
  10. 1.4.1 Global Breast Cancer Screening Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Breast Cancer Screening Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Breast Cancer Screening Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Breast Cancer Screening Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Breast Cancer Screening Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Breast Cancer Screening Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Breast Cancer Screening Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Breast Cancer Screening Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Breast Cancer Screening Industry Trends
  2. 2.2 Breast Cancer Screening Industry Drivers
  3. 2.3 Breast Cancer Screening Industry Opportunities and Challenges
  4. 2.4 Breast Cancer Screening Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Breast Cancer Screening Revenue (2021-2026)
  2. 3.2 Global Top Players by Breast Cancer Screening Sales (2021-2026)
  3. 3.3 Global Top Players by Breast Cancer Screening Price (2021-2026)
  4. 3.4 Global Breast Cancer Screening Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Breast Cancer Screening Major Company Production Sites & Headquarters
  6. 3.6 Global Breast Cancer Screening Company, Product Type & Application
  7. 3.7 Global Breast Cancer Screening Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Breast Cancer Screening Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Breast Cancer Screening Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Breast Cancer Screening Tier 1, Tier 2, and Tier 3
4 Breast Cancer Screening Regional Status and Outlook
  1. 4.1 Global Breast Cancer Screening Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Breast Cancer Screening Historic Market Size by Region
  3. 4.2.1 Global Breast Cancer Screening Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Breast Cancer Screening Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Breast Cancer Screening Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Breast Cancer Screening Forecasted Market Size by Region
  7. 4.3.1 Global Breast Cancer Screening Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Breast Cancer Screening Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Breast Cancer Screening Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Breast Cancer Screening by Application
  1. 5.1 Breast Cancer Screening Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Breast Cancer Screening Market Size by Application
  5. 5.2.1 Global Breast Cancer Screening Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Breast Cancer Screening Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Breast Cancer Screening Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Breast Cancer Screening Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Breast Cancer Screening Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Breast Cancer Screening Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Breast Cancer Screening Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Breast Cancer Screening Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hologic
  2. 6.1.1 Hologic Company Information
  3. 6.1.2 Hologic Business Overview
  4. 6.1.3 Hologic Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hologic Breast Cancer Screening Product Portfolio
  6. 6.1.5 Hologic Recent Developments
  7. 6.2 GE Healthcare
  8. 6.2.1 GE Healthcare Company Information
  9. 6.2.2 GE Healthcare Business Overview
  10. 6.2.3 GE Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GE Healthcare Breast Cancer Screening Product Portfolio
  12. 6.2.5 GE Healthcare Recent Developments
  13. 6.3 Siemen Healthineers
  14. 6.3.1 Siemen Healthineers Company Information
  15. 6.3.2 Siemen Healthineers Business Overview
  16. 6.3.3 Siemen Healthineers Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Siemen Healthineers Breast Cancer Screening Product Portfolio
  18. 6.3.5 Siemen Healthineers Recent Developments
  19. 6.4 Philips Healthcare
  20. 6.4.1 Philips Healthcare Company Information
  21. 6.4.2 Philips Healthcare Business Overview
  22. 6.4.3 Philips Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Philips Healthcare Breast Cancer Screening Product Portfolio
  24. 6.4.5 Philips Healthcare Recent Developments
  25. 6.5 Canon Medical
  26. 6.5.1 Canon Medical Company Information
  27. 6.5.2 Canon Medical Business Overview
  28. 6.5.3 Canon Medical Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Canon Medical Breast Cancer Screening Product Portfolio
  30. 6.5.5 Canon Medical Recent Developments
  31. 6.6 Fujifilm
  32. 6.6.1 Fujifilm Company Information
  33. 6.6.2 Fujifilm Business Overview
  34. 6.6.3 Fujifilm Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Fujifilm Breast Cancer Screening Product Portfolio
  36. 6.6.5 Fujifilm Recent Developments
  37. 6.7 Metaltronica
  38. 6.7.1 Metaltronica Company Information
  39. 6.7.2 Metaltronica Business Overview
  40. 6.7.3 Metaltronica Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Metaltronica Breast Cancer Screening Product Portfolio
  42. 6.7.5 Metaltronica Recent Developments
  43. 6.8 Sino Medical-Device
  44. 6.8.1 Sino Medical-Device Company Information
  45. 6.8.2 Sino Medical-Device Business Overview
  46. 6.8.3 Sino Medical-Device Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sino Medical-Device Breast Cancer Screening Product Portfolio
  48. 6.8.5 Sino Medical-Device Recent Developments
  49. 6.9 IMS Srl
  50. 6.9.1 IMS Srl Company Information
  51. 6.9.2 IMS Srl Business Overview
  52. 6.9.3 IMS Srl Breast Cancer Screening Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 IMS Srl Breast Cancer Screening Product Portfolio
  54. 6.9.5 IMS Srl Recent Developments
7 North America by Country
  1. 7.1 North America Breast Cancer Screening Sales by Country
  2. 7.1.1 North America Breast Cancer Screening Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Breast Cancer Screening Sales by Country (2021-2026)
  4. 7.1.3 North America Breast Cancer Screening Sales Forecast by Country (2027-2032)
  5. 7.2 North America Breast Cancer Screening Market Size by Country
  6. 7.2.1 North America Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Breast Cancer Screening Market Size by Country (2021-2026)
  8. 7.2.3 North America Breast Cancer Screening Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Breast Cancer Screening Sales by Country
  2. 8.1.1 Europe Breast Cancer Screening Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Breast Cancer Screening Sales by Country (2021-2026)
  4. 8.1.3 Europe Breast Cancer Screening Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Breast Cancer Screening Market Size by Country
  6. 8.2.1 Europe Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Breast Cancer Screening Market Size by Country (2021-2026)
  8. 8.2.3 Europe Breast Cancer Screening Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Breast Cancer Screening Sales by Country
  2. 9.1.1 Asia-Pacific Breast Cancer Screening Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Breast Cancer Screening Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Breast Cancer Screening Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Breast Cancer Screening Market Size by Country
  6. 9.2.1 Asia-Pacific Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Breast Cancer Screening Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Breast Cancer Screening Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Breast Cancer Screening Sales by Country
  2. 10.1.1 South America Breast Cancer Screening Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Breast Cancer Screening Sales by Country (2021-2026)
  4. 10.1.3 South America Breast Cancer Screening Sales Forecast by Country (2027-2032)
  5. 10.2 South America Breast Cancer Screening Market Size by Country
  6. 10.2.1 South America Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Breast Cancer Screening Market Size by Country (2021-2026)
  8. 10.2.3 South America Breast Cancer Screening Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Breast Cancer Screening Sales by Country
  2. 11.1.1 Middle East and Africa Breast Cancer Screening Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Breast Cancer Screening Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Breast Cancer Screening Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Breast Cancer Screening Market Size by Country
  6. 11.2.1 Middle East and Africa Breast Cancer Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Breast Cancer Screening Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Breast Cancer Screening Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Breast Cancer Screening Value Chain Analysis
  2. 12.1.1 Breast Cancer Screening Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Breast Cancer Screening Production Mode & Process
  7. 12.2 Breast Cancer Screening Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Breast Cancer Screening Distributors
  10. 12.2.3 Breast Cancer Screening Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst